Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities
Net income	$ (539,260)	$ (323,942)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation expense	288	859
Stock based compensation	0	76,977
Amortization of debt discount	96,095	63,625
Amortization of right-of-use assets	24,962	20,225
Interest expense from derivative issuance	0	141,020
Derivative (gain) loss	330,806	(435,730)
Inventory impairment	0	18,800
Net change in:
Accounts receivable	(25,605)	(283,138)
Inventory	(1,843)	(30,545)
Prepaid expenses	(42,054)	(85,779)
Right-of-use liabilities	(25,119)	(17,916)
Accounts payable and accrued expenses	139,343	324,327
Deferred revenue	(274,250)	(23,999)
Net cash used in operating activities	(316,637)	(555,216)
Cash Flows from Financing Activities
Proceeds from line of credit	50,000	0
Payments on convertible notes payable	0	(300,000)
Payment of debt issuance costs	(1,000)	0
Proceeds from notes payable	0	231,194
Payments on notes payable	(69,737)	(312,009)
Proceeds from issuance of Series A preferred stock	0	890,000
Net cash provided by financing activities	(20,737)	509,185
Net Change in Cash	(337,374)	(46,031)
Cash, Beginning of Period	482,908	344,811
Cash, End of Period	145,534	298,780
Cash Paid For:
Income Taxes	0	0
Interest	8,691	13,709
Non-cash transactions:
Right of use asset and liability recognized, operating leases	0	105,822
Common stock issued for deferred finance costs	0	2,670
Common stock issued to settle share payable	0	331,600
Preferred stock dividends	$ 69,259	$ 45,920